These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

215 related articles for article (PubMed ID: 33511940)

  • 61. Synthesis of novel acridine bis-sulfonamides with effective inhibitory activity against the carbonic anhydrase isoforms I, II, IX and XII.
    Esirden İ; Ulus R; Aday B; Tanç M; Supuran CT; Kaya M
    Bioorg Med Chem; 2015 Oct; 23(20):6573-80. PubMed ID: 26422787
    [TBL] [Abstract][Full Text] [Related]  

  • 62. Novel sulfonamide-containing 2-indolinones that selectively inhibit tumor-associated alpha carbonic anhydrases.
    Karalı N; Akdemir A; Göktaş F; Eraslan Elma P; Angeli A; Kızılırmak M; Supuran CT
    Bioorg Med Chem; 2017 Jul; 25(14):3714-3718. PubMed ID: 28545816
    [TBL] [Abstract][Full Text] [Related]  

  • 63. Application of hydrazino and hydrazido linkers to connect benzenesulfonamides with hydrophilic/phobic tails for targeting the middle region of human carbonic anhydrases active site: Selective inhibitors of hCA IX.
    Allam HA; Fahim SH; F Abo-Ashour M; Nocentini A; Elbakry ME; Abdelrahman MA; Eldehna WM; Ibrahim HS; Supuran CT
    Eur J Med Chem; 2019 Oct; 179():547-556. PubMed ID: 31276899
    [TBL] [Abstract][Full Text] [Related]  

  • 64. Benzenesulfonamides incorporating bulky aromatic/heterocyclic tails with potent carbonic anhydrase inhibitory activity.
    Bozdag M; Alafeefy AM; Vullo D; Carta F; Dedeoglu N; Al-Tamimi AM; Al-Jaber NA; Scozzafava A; Supuran CT
    Bioorg Med Chem; 2015 Dec; 23(24):7751-64. PubMed ID: 26639945
    [TBL] [Abstract][Full Text] [Related]  

  • 65. Kinetic and X-ray crystallographic investigations on carbonic anhydrase isoforms I, II, IX and XII of a thioureido analog of SLC-0111.
    Lomelino CL; Mahon BP; McKenna R; Carta F; Supuran CT
    Bioorg Med Chem; 2016 Mar; 24(5):976-81. PubMed ID: 26810836
    [TBL] [Abstract][Full Text] [Related]  

  • 66. Synthesis and exploration of 2-morpholino-4-phenylthiazol-5-yl acrylamide derivatives for their effects against carbonic anhydrase I, II, IX and XII isoforms as a non-sulfonamide class of inhibitors.
    Swain B; Singh Digwal C; Angeli A; Alvala M; Singh P; Supuran CT; Arifuddin M
    Bioorg Med Chem; 2019 Nov; 27(21):115090. PubMed ID: 31515058
    [TBL] [Abstract][Full Text] [Related]  

  • 67. Novel 4/3-((4-oxo-5-(2-oxoindolin-3-ylidene)thiazolidin-2-ylidene)amino) benzenesulfonamides: Synthesis, carbonic anhydrase inhibitory activity, anticancer activity and molecular modelling studies.
    Eldehna WM; Abo-Ashour MF; Nocentini A; Gratteri P; Eissa IH; Fares M; Ismael OE; Ghabbour HA; Elaasser MM; Abdel-Aziz HA; Supuran CT
    Eur J Med Chem; 2017 Oct; 139():250-262. PubMed ID: 28802125
    [TBL] [Abstract][Full Text] [Related]  

  • 68. Click-tailed coumarins with potent and selective inhibitory action against the tumor-associated carbonic anhydrases IX and XII.
    Nocentini A; Carta F; Ceruso M; Bartolucci G; Supuran CT
    Bioorg Med Chem; 2015 Nov; 23(21):6955-66. PubMed ID: 26432607
    [TBL] [Abstract][Full Text] [Related]  

  • 69. Synthesis of coumarin-sulfonamide derivatives and determination of their cytotoxicity, carbonic anhydrase inhibitory and molecular docking studies.
    Zengin Kurt B; Sonmez F; Ozturk D; Akdemir A; Angeli A; Supuran CT
    Eur J Med Chem; 2019 Dec; 183():111702. PubMed ID: 31542715
    [TBL] [Abstract][Full Text] [Related]  

  • 70. New anthranilic acid-incorporating N-benzenesulfonamidophthalimides as potent inhibitors of carbonic anhydrases I, II, IX, and XII: Synthesis, in vitro testing, and in silico assessment.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Almehizia AA; Alanazi MM; Hefnawy MM; Supuran CT
    Eur J Med Chem; 2019 Nov; 181():111573. PubMed ID: 31394463
    [TBL] [Abstract][Full Text] [Related]  

  • 71. Exploring of tumor-associated carbonic anhydrase isoenzyme IX and XII inhibitory effects and cytotoxicities of the novel N-aryl-1-(4-sulfamoylphenyl)-5-(thiophen-2-yl)-1H-pyrazole-3-carboxamides.
    Yamali C; Inci Gul H; Ozli G; Angeli A; Ballar Kirmizibayrak P; Erbaykent Tepedelen B; Sakagami H; Bua S; Supuran CT
    Bioorg Chem; 2021 Oct; 115():105194. PubMed ID: 34365059
    [TBL] [Abstract][Full Text] [Related]  

  • 72. Design, synthesis, characterization, in vitro and in silico evaluation of novel imidazo[2,1-b][1,3,4]thiadiazoles as highly potent acetylcholinesterase and non-classical carbonic anhydrase inhibitors.
    Askin S; Tahtaci H; Türkeş C; Demir Y; Ece A; Akalın Çiftçi G; Beydemir Ş
    Bioorg Chem; 2021 Aug; 113():105009. PubMed ID: 34052739
    [TBL] [Abstract][Full Text] [Related]  

  • 73. Sulfonamides incorporating boroxazolidone moieties are potent inhibitors of the transmembrane, tumor-associated carbonic anhydrase isoforms IX and XII.
    Rami M; Maresca A; Smaine FZ; Montero JL; Scozzafava A; Winum JY; Supuran CT
    Bioorg Med Chem Lett; 2011 May; 21(10):2975-9. PubMed ID: 21470859
    [TBL] [Abstract][Full Text] [Related]  

  • 74. Benzenesulfonamide bearing imidazothiadiazole and thiazolotriazole scaffolds as potent tumor associated human carbonic anhydrase IX and XII inhibitors.
    Kumar R; Bua S; Ram S; Del Prete S; Capasso C; Supuran CT; Sharma PK
    Bioorg Med Chem; 2017 Feb; 25(3):1286-1293. PubMed ID: 28065499
    [TBL] [Abstract][Full Text] [Related]  

  • 75. Sulfocoumarin-, Coumarin-, 4-Sulfamoylphenyl-Bearing Indazole-3-carboxamide Hybrids: Synthesis and Selective Inhibition of Tumor-Associated Carbonic Anhydrase Isozymes IX and XII.
    Angapelly S; Sri Ramya PV; Angeli A; Supuran CT; Arifuddin M
    ChemMedChem; 2017 Oct; 12(19):1578-1584. PubMed ID: 28940980
    [TBL] [Abstract][Full Text] [Related]  

  • 76. Novel indolin-2-one-based sulfonamides as carbonic anhydrase inhibitors: Synthesis, in vitro biological evaluation against carbonic anhydrases isoforms I, II, IV and VII and molecular docking studies.
    Eldehna WM; Al-Ansary GH; Bua S; Nocentini A; Gratteri P; Altoukhy A; Ghabbour H; Ahmed HY; Supuran CT
    Eur J Med Chem; 2017 Feb; 127():521-530. PubMed ID: 28109946
    [TBL] [Abstract][Full Text] [Related]  

  • 77. Carbonic anhydrase inhibitors. Inhibition of the cytosolic and tumor-associated carbonic anhydrase isozymes I, II, and IX with a series of 1,3,4-thiadiazole- and 1,2,4-triazole-thiols.
    Almajan GL; Innocenti A; Puccetti L; Manole G; Barbuceanu S; Saramet I; Scozzafava A; Supuran CT
    Bioorg Med Chem Lett; 2005 May; 15(9):2347-52. PubMed ID: 15837323
    [TBL] [Abstract][Full Text] [Related]  

  • 78. Carbonic anhydrase inhibitors: in vitro inhibition of α isoforms (hCA I, hCA II, bCA III, hCA IV) by flavonoids.
    Ekinci D; Karagoz L; Ekinci D; Senturk M; Supuran CT
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):283-8. PubMed ID: 22168126
    [TBL] [Abstract][Full Text] [Related]  

  • 79. S-substituted 2-mercaptoquinazolin-4(3H)-one and 4-ethylbenzensulfonamides act as potent and selective human carbonic anhydrase IX and XII inhibitors.
    El-Azab AS; Abdel-Aziz AA; Bua S; Nocentini A; AlSaif NA; Alanazi MM; El-Gendy MA; Ahmed HEA; Supuran CT
    J Enzyme Inhib Med Chem; 2020 Dec; 35(1):733-743. PubMed ID: 32189526
    [TBL] [Abstract][Full Text] [Related]  

  • 80. Three new aromatic sulfonamide inhibitors of carbonic anhydrases I, II, IV and XII.
    Supuran CT; Maresca A; Gregáň F; Remko M
    J Enzyme Inhib Med Chem; 2013 Apr; 28(2):289-93. PubMed ID: 22299577
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 11.